CFO of Array BioPharma Inc. (ARRY, Financial) Michael Carruthers sells 1,707 shares of ARRY on 02/23/2010 at an average price of $2.4 a share.
Array Biopharma Inc. has a market cap of $119.8 million; its shares were traded at around $2.43 with and P/S ratio of 4.8. Array Biopharma Inc. had an annual average earning growth of 32.7% over the past 5 years.
ARRY is in the portfolios of Jean-Marie Eveillard of Arnhold & S. Bleichroeder Advisers, LLC, Jim Simons of RENAISSANCE TECHNOLOGIES LLC, Jim Simons of RENAISSANCE TECHNOLOGIES LLC.
Array Biopharma Inc. has a market cap of $119.8 million; its shares were traded at around $2.43 with and P/S ratio of 4.8. Array Biopharma Inc. had an annual average earning growth of 32.7% over the past 5 years.
ARRY is in the portfolios of Jean-Marie Eveillard of Arnhold & S. Bleichroeder Advisers, LLC, Jim Simons of RENAISSANCE TECHNOLOGIES LLC, Jim Simons of RENAISSANCE TECHNOLOGIES LLC.
CFO Recent Trades:
- Sell:: CFO Michael Carruthers sold 6,286 shares of ARRY stock on 02/05/2010 at the average price of 2.44, the price of the stock has decreased by 0.41% since.
- Sell:: CFO Michael Carruthers sold 1,644 shares of ARRY stock on 01/22/2010 at the average price of 2.49, the price of the stock has decreased by 2.41% since.
- Sell:: CFO Michael Carruthers sold 5,681 shares of ARRY stock on 01/06/2010 at the average price of 2.69, the price of the stock has decreased by 9.67% since.
- Sell:: CFO Michael Carruthers sold 1,533 shares of ARRY stock on 12/23/2009 at the average price of 2.66, the price of the stock has decreased by 8.65% since.
- Sell:: CFO Michael Carruthers sold 2,045 shares of ARRY stock on 11/23/2009 at the average price of 2.01, the price of the stock has increased by 20.9% since.
